| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000046523 |
| Receipt No. | R000053082 |
| Scientific Title | Effect of bright light exposure on the circadian rhythm of the elderly |
| Date of disclosure of the study information | 2022/01/10 |
| Last modified on | 2022/01/03 (Ver. 1) |
| Basic information | ||
| Public title | Effect of bright light exposure on the circadian rhythm of the elderly | |
| Acronym | Effect of bright light exposure on the circadian rhythm of the elderly | |
| Scientific Title | Effect of bright light exposure on the circadian rhythm of the elderly | |
| Scientific Title:Acronym | Effect of bright light exposure on the circadian rhythm of the elderly | |
| Region |
|
|
| Condition | ||
| Condition | Elderly people | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Investigate the effect of bright light exposure on the circadian rhythm of the elderly in daily life. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Urinary melatonin |
| Key secondary outcomes | 1. Salivary melatonin
2. Salivary cortisol 3. Sleep parameters(sleep onset latency, sleep efficiency, total sleep time, wake after sleep onset, subjective sleep quality) 4. Volume of activity |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 2 weeks light exposure | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Individuals can collect the required amount of saliva (about 1.9 g) in 5 minutes
2. Individuals can understand the research contents |
|||
| Key exclusion criteria | 1. Individuals with SARS-CoV-2
2. Patients with insomnia or sleep apnea syndrome or restless legs syndrome 3. Patients with psychological diseases or dementia 4. Patients with severe eye diseases 5. Smokers 6. Individuals with alcohol drinking habit 7. Individuals with Long-term Care Need at levels 4 or more 8. Shift workers or night workers 9. Others who the researcher judged inappropriate |
|||
| Target sample size | 15 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shionogi & Co., Ltd. | ||||||
| Division name | Digital Intelligence department | ||||||
| Zip code | 541-0045 | ||||||
| Address | 1-8, Doshomachi 3-chome, Chuo-ku, Osaka, Japan | ||||||
| TEL | 080-2506-1404 | ||||||
| tatsuya.yanagawa@shionogi.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shionogi & Co., Ltd. | ||||||
| Division name | Digital Intelligence department | ||||||
| Zip code | 541-0045 | ||||||
| Address | 1-8, Doshomachi 3-chome, Chuo-ku, Osaka, Japan | ||||||
| TEL | 080-2506-1404 | ||||||
| Homepage URL | |||||||
| tatsuya.yanagawa@shionogi.co.jp | |||||||
| Sponsor | |
| Institute | Shionogi & Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shionogi & Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Shionogi research IRB |
| Address | 3-1-1, Futaba-cho, Toyonaka city, Osaka, Japan |
| Tel | 070-7812-7654 |
| takeshi.itoh@shionogi.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 15 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053082 |